The biopharmaceutical company, which was co-founded by Ionis Pharmaceuticals, has secured funding in an Andera Partners-led round.

Andera Partners has led a $55m funding round for Dynacure, co-founded by Satt Conectus to commercialise research from the Institute of Genetic and Molecular and Cellular Biology.

Essence Group Holdings, the owner of care services provider Lumeris, has formed a partnership with new strategic investor Cerner.

The Leap Fund will back early-stage, risky research that would not be able to secure funding through other channels.

Gunilla Lundmark has been hired as managing director of Uppsala University Holding, succeeding founding chief executive Lars Jonsson.

Unternehmertum Venture Capital Partners has agreed to sell its shares in AMW as part of an acquisition led by Hybio Pharmaceutical and Yunfeng Capital.

Microbiological labelling system developer C4 Diagnostics, which is partly based on Aix-Marseille Université research, has been backed by investors including Bpifrance.

Colposcope developer Dysis has closed a series B round featuring existing investor Lundbeckfonden Ventures that will fund growth and R&D.

Initial public offerings of companies from the life sciences sector appear to be rebounding in number during the first half of 2018 and news stories on our web from the past couple weeks clearly attest to it.